Epidermal growth factor receptor tyrosine kinase inhibitorsRANSON, M.British journal of cancer. 2004, Vol 90, Num 12, pp 2250-2255, issn 0007-0920, 6 p.Article

Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytesYAMAKI, Mayuko; SUGIURA, Kazumitsu; MURO, Yoshinao et al.Experimental dermatology. 2010, Vol 19, Num 8, pp 730-735, issn 0906-6705, 6 p.Article

High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancerJEFFREY PETTY, W; VOELZKE, William R; URBANIC, James J et al.Lung cancer. 2011, Vol 74, Num 3, pp 384-391, issn 0169-5002, 8 p.Article

Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosisWU, Shang-Gin; HU, Fu-Chang; CHANG, Yih-Leong et al.The European respiratory journal. 2013, Vol 41, Num 2, pp 417-424, issn 0903-1936, 8 p.Article

EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-upRUPPERT, A.-M; BEAU-FALLER, M; OUDET, P et al.The European respiratory journal. 2009, Vol 33, Num 2, pp 436-440, issn 0903-1936, 5 p.Article

Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsRONGHUI LIN; JOHNSON, Sigmond G; FUENTES-PESQUERA, Angel R et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 8, pp 2333-2337, issn 0960-894X, 5 p.Article

Targeting epidermal growth factor receptor: Central signaling kinase in lung cancerYOSHIDA, Takeshi; GUOLIN ZHANG; HAURA, Eric B et al.Biochemical pharmacology. 2010, Vol 80, Num 5, pp 613-623, issn 0006-2952, 11 p.Article

Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasisKIM, Jeong-Eun; DAE HO LEE; CHOI, Yunsuk et al.Lung cancer. 2009, Vol 65, Num 3, pp 351-354, issn 0169-5002, 4 p.Article

In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell linesHUA CHENG; AN, She-Juan; ZHANG, Xu-Chao et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 3, pp 637-646, issn 0344-5704, 10 p.Article

Brief report : Retrospective review of efficacy of erlotinib or gefitinib compared to docetaxel as subsequent line therapy in advanced non-small cell lung cancer (NSCLC) following failure of platinum-based chemotherapyNG, Raymond; LORETO, Michael; LEE, Roy et al.Lung cancer. 2008, Vol 61, Num 2, pp 262-265, issn 0169-5002, 4 p.Article

Synthesis of [¹¹C]Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinaseWANG, Ji-Quan; MINGZHANG GAO; MILLER, Kathy D et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 15, pp 4102-4106, issn 0960-894X, 5 p.Article

Oropharyngeal cancers: Relationship between epidermal growth factor receptor alterations and human papillomavirus statusMIRGHANI, H; AMEN, F; MOREAU, F et al.European journal of cancer (1990). 2014, Vol 50, Num 6, pp 1100-1111, issn 0959-8049, 12 p.Article

Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: A case report and review of the literatureTOGASHI, Yosuke; MASAGO, Katsuhiro; HAMATANI, Yasuhiro et al.Lung cancer. 2012, Vol 77, Num 2, pp 464-468, issn 0169-5002, 5 p.Article

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancerWONG, Matthew K; LO, Alvis I; LAM, Bing et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 6, pp 1023-1028, issn 0344-5704, 6 p.Article

The gefitinib long-term responder (LTR)―A cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)GOTTSCHLING, Sandra; HERPEL, Esther; BISCHOFF, Helge G et al.Lung cancer. 2012, Vol 77, Num 1, pp 183-191, issn 0169-5002, 9 p.Article

Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinomaYOSHIDA, Tatsuya; ISHII, Genichiro; OCHIAI, Atsushi et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 10, pp 1691-1700, issn 0171-5216, 10 p.Article

Successful treatment with erlotinib of severe neutropenia induced by gefitinib in a patient with advanced non-small cell lung cancerARAYA, Tomoyuki; KASAHARA, Kazuo; DEMURA, Yoshiki et al.Lung cancer. 2013, Vol 80, Num 3, pp 344-346, issn 0169-5002, 3 p.Article

Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma NSCLC patients with EGFR mutationCHO, Su-Hee; LEE CHUN PARK; PARK, Keunchil et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 2, pp 315-320, issn 0344-5704, 6 p.Article

Phase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to GefitinibASAHINA, Hajime; OIZUMI, Satoshi; DOSAKA-AKITA, Hirotoshi et al.Oncology. 2010, Vol 79, Num 5-6, pp 423-429, issn 0030-2414, 7 p.Article

Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839ZEMBUTSU, Hitoshi; OHNISHI, Yasuyuki; DAIGO, Yataro et al.International journal of oncology. 2003, Vol 23, Num 1, pp 29-39, issn 1019-6439, 11 p.Article

Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZDI839) in non-small-cell lung cancerPARRA, H. S; CAVINA, R; LATTERI, F et al.British journal of cancer. 2004, Vol 91, Num 2, pp 208-212, issn 0007-0920, 5 p.Article

Rebiopsy of Non―Small Cell Lung Cancer Patients With Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor: Comparison Between T790M Mutation-Positive and Mutation-Negative PopulationsHATA, Akito; KATAKAMI, Nobuyuki; MATSUMOTO, Takeshi et al.Cancer. 2013, Vol 119, Num 24, pp 4325-4332, issn 0008-543X, 8 p.Article

Present and potential future issues in glioblastoma treatmentLEFRANC, Florence; SADEGHI, Niloufar; CAMBY, Isabelle et al.Expert review of anticancer therapy. 2006, Vol 6, Num 5, pp 719-732, issn 1473-7140, 14 p.Article

Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitorsLEI DONG; HAN, Zhao-Feng; FENG, Zi-Hui et al.Journal of international medical research. 2014, Vol 42, Num 1, pp 191-197, issn 0300-0605, 7 p.Article

Icotinib: activity and clinical application in Chinese patients with lung cancerGUAN, Yong-Song; QING HE; MEI LI et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 5, pp 717-728, issn 1465-6566, 12 p.Article